Dedicated to clinical corrective and preventive actions, ExL Pharma is offering the 3rd Developing CAPAs in the GCP Environment Conference on January 24-25 in Arlington, VA. The event has become a gathering for companies of all sizes and types to discuss and share...
A recent article by Canadian Medical Association Journal discusses how the Helsinki doctrine is under review. The World Medical Association will revise the Declaration of Helsinki before the famous doctrine celebrates its 50th anniversary in 2014. Revisions are not...
FierceBiotech has compiled a list of the 20 top pharma-academic collaborations from 2012 which can be found here. This list notes the Big Pharma players who have collaborated with universities and academic medical centers and gone above and beyond typical research...
The Food and Drug Administration has made the decision to effectuate two provisions of the user fee law in hopes to amplify the voice of the patient in the process of drug development. This action will surely be celebrated by many patient groups and disease advocacy...
While there are many different size clinical research sites, competition becomes increasingly difficult for smaller sites with smaller amounts of employees, resources, etc.. In a recent article written by Gina Nesbit, a hypothetical site is created, Acme Research,...
Although the elderly are often considered ineligible for clinical trials, experts in a recent article from Outsourcing-pharma.com are saying the age group “must be taken into consideration more often during research.” Clinical trials are intended to be...
